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Abstract
Huntington’s disease is a fatal, neurodegenerative movement disorder characterized by
preferential and extensive striatal degeneration. Here, we used fast-scan cyclic voltammetry to
study the mobilization and efflux of reserve pool dopamine in striatal brain slices from
Huntington’s disease model R6/2 mice. When applying stimulus trains of 120 pulses, evoked
dopamine release in wild-type slices was greater than that in R6/2 slices at the higher frequencies
(50 and 60 Hz). To quantify cytosolic and reserve pool dopamine levels, amphetamine-induced
dopamine efflux was measured after pre-treatment with either tetrabenazine or alpha-methyl-p-
tyrosine. Slices from 12-week old R6/2 mice released less dopamine than slices from wild-type
mice, while no difference was noted in slices from 6-week old mice. The vesicular release of
reserve pool dopamine, mobilized by treatment with cocaine, was shorter lived in R6/2 slices
compared to wild-type slices even though peak dopamine release was the same. Moreover, the
number of dopamine reserve pool vesicles in R6/2 mice was less than half of that in wild-type.
Therefore, our data suggest that the same number of dopamine molecules are present in each
reserve pool vesicle in WT and R6/2 mice and that these vesicles are readily mobilized in both
genotypes; however, R6/2 mice have fewer dopamine reserve pool vesicles available for
mobilization.
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Introduction
Huntington’s disease (HD) is an autosomal dominant neurodegenerative movement disorder
caused by an expanded CAG repeat on the gene that encodes the huntingtin protein (htt).
HD is characterized by mood disturbances, choreic movements, cognitive dysfunction, and
degeneration of the striatum (Bates et al., 2002). Recent evidence indicates that impaired
striatal dopamine (DA) release in HD rodent models contributes to the progressive motor
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phenotype. This evidence includes: in vivo microdialysis studies in which DA levels in R6/1
and R6/2 mice were lower than that of wild type (WT) controls (Abercrombie and Russo,
2002; Petersén et al., 2002); locomotor measurements in which R6/2 mice had a blunted
response to cocaine (COC) and methamphetamine (METH; Hickey et al., 2002; Johnson et
al., 2006); and stimulated DA release measurements taken using fast-scan cyclic
voltammetry (FSCV) in which release in R6/2 brain slices was impaired (Johnson et al.,
2006; Johnson et al., 2007). Furthermore, amperometry data collected from adrenal
chromaffin cells suggest that quantal release of catecholamines is diminished in R6/2 mice
(Johnson et al., 2007). Nevertheless, specific mechanisms underlying presynaptic DA
release impairments in striatal brain tissue have not yet been thoroughly investigated.
One potential mechanism of striatal dysfunction in R6/2 mice involves the mobilization of
reserve pool DA. Vesicles containing DA are believed to be partitioned into three distinct
pools. These pools include the readily releasable pool (RRP), which undergoes exocytosis
upon mild stimulation, the recycling pool, which is mobilized to replace RRP vesicles, and
the reserve pool, which is thought to be mobilized during periods of prolonged synaptic
activity (Neves and Lagnado, 1999; Zucker and Regehr, 2002; Rizzoli and Betz, 2005). The
reserve pool is the largest vesicle pool, consisting of ~80–90% of the total vesicles in
presynaptic terminals (Neves and Lagnado, 1999; Rizzoli and Betz, 2005). It has been
shown previously that a synapsin-dependent DA reserve pool can be mobilized by treatment
with COC (Venton et al., 2006). Thus, not only does this study suggest a possible
mechanism for the attenuated psychostimulatory effect of COC in R6/2 mice, but it also
identifies a mechanism by which DA reserve pools can be pharmacologically manipulated.
In this work, we investigated the neurochemical mechanisms that underlie striatal DA
release impairments, which could potentially amplify phenotypical behavioral impairments
observed in R6/2 mice (Carter et al. 1999). We hypothesized that reserve pool DA is
depleted in R6/2 mice. To investigate this possibility, FSCV was used to measure
amphetamine (AMPH) induced efflux and COC-induced vesicle mobilization of reserve
pool DA in acute striatal slices from R6/2 and WT control mice. Our results suggest not only
that the amount of striatal reserve dopamine is diminished in R6/2 mice, but also that this
decrease is associated with a decline in the number of DA reserve pool vesicles available for
mobilization.
Materials and Methods
Drugs
COC, αMPT, and AMPH were purchased from Sigma-Aldrich (St. Louis, MO).
Tetrabenazine (TBZ) was a generous gift from Prof. Eric Floors, Department of Molecular
Biosciences, University of Kansas.
Animals
R6/2 [B6CBA-Tg(HDexon1)62Gpb] and wild-type mice were purchased from Jackson
Laboratories (Bar Harbor, Maine) and were housed at the University of Kansas animal care
unit prior to use. Food and water were provided ad libitum and a 12-hour light-dark cycle
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was used. All animal procedures were approved by the Institutional Animal Care and Use
Committee.
Brain Slice Preparation
Brain slices were prepared as previously described (Johnson et al., 2006). Briefly, mice were
anesthetized by isoflurane inhalation and then decapitated. The brain was immediately
removed and placed in ice cold artificial cerebrospinal fluid (aCSF). The aCSF consisted of
126 mM NaCl, 2.5 mM KCl, 1.2 mM NaH2PO4, 2.4 mM CaCl2, 1.2 mM MgCl2, 25 mM
NaHCO3, 20 mM HEPES, and 11 mM D-Glucose. The pH was adjusted to 7.4. During the
brain slice harvesting procedure and during experimentation, the aCSF was continuously
saturated with 95% O2/5% CO2. The cerebellum was sliced off with a razor blade and then
the brain was mounted on an aluminum block. Coronal slices, 300 µm thick, were made
using a vibratome slicer (Leica, Wetzlar, Germany). Brain slices containing striata were
stored in ice cold aCSF. A single slice was placed in the superfusion chamber, through
which aCSF, maintained at 34° C, flowed at a continuous rate of 2 mL/min. Each brain slice
was equilibrated in the superfusion chamber for 60 minutes prior to obtaining
measurements. To apply αMPT, TBZ, AMPH, and COC, aCSF containing these drugs was
maintained in a separate reservoir and introduced through a three-way valve.
DA release in brain slices
Carbon-fiber microelectrodes were fabricated as previously described (Kraft et al., 2009),
with minor changes. Briefly, a single 7 µm diameter carbon-fiber (Goodfellow Cambridge
Ltd, Huntingdon, U.K.) was aspirated through a glass capillary tube (1.2 mm outer diameter,
0.68 mm inner diameter, 4 inches long, A-M Systems, Inc. Carlsborg, WA, USA), which
was pulled using a heated coil puller (Narishige International USA, Inc., East Meadow,
NY). Electrodes were trimmed to 25 µm from the glass seal, further insulated with epoxy
resin (EPON resin 815C, EPIKURE 3234 curing agent, Miller-Stephenson, Danbury, CT,
USA), and then cured at 100?C for 1 h. Prior to experimentation, electrodes were backfilled
with 0.5 M potassium acetate in order to provide an electrical connection between the
carbon fiber and an inserted silver wire. No further treatment of the electroactive surface
was performed.
A triangular waveform, starting at −0.4 V, increasing to +1.0 V, and then scanning back to
−0.4 V, was applied at the carbon-fiber working electrode. A scan rate of 300 V/s was used
with an update rate of 60 Hz for single pulse stimulations and 10 Hz for 120-pulse
stimulations. A headstage amplifier (UNC Chemistry Department Electronics Design
Facility, Chapel Hill, NC) was interfaced with a computer via a breakout box and custom
software provided by R.M. Wightman and M.L.A.V. Heien, University of North Carolina,
Chapel Hill. A chlorided silver wire was used as an Ag/AgCl reference electrode. The
carbon fiber microelectrode was inserted 100 µm into the dorsolateral caudate-putamen
region of the striatum between the prongs of a bipolar stimulation electrode (Plastics One,
Roanoke, VA), which was separated by a distance of 200 µm. The current was then
measured at the peak oxidation potential for dopamine (about +0.6V versus Ag/AgCl
reference electrode). For the 120-pulse stimulations, DA release was measured using
stimulation frequencies of 20, 30, 40, 50, and 60 Hz at four locations in the dorsolateral
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striatum. At each location the DA release was measured going from the lowest frequency
(20 Hz) to the highest frequency (60 Hz) with a 5 minute recovery time between each
measurement. Working electrodes were calibrated with dopamine standards of known
concentration in a flow cell before and after each use. The average of the pre and post
calibration measurements was used as the calibration factor.
For DA efflux studies, single stimulus pulses were applied every five minutes until peak
dopamine release was consistent over three consecutive measurements. Once the DA release
was consistent, either 50 µM αMPT or 10µM TBZ was added to the aCSF. The brain slice
was stimulated every 5 minutes until the DA release peak disappeared. Next, 20 µM AMPH
was introduced into the aCSF perfusion solution in addition to the αMPT or TBZ that was
already present. AMPH-induced efflux was then measured without the use of electrical
stimulation over the course of 25 minutes with an update rate of 5 Hz. This update rate was
used in order to limit the amount of memory required for storage of the file. These data were
also background-subtracted and collected at the same scan rate and potential limits as the
stimulated release data. For studies using COC, the previous procedure for αMPT was
followed except that once the DA release peak disappeared, 20µM COC was added to the
αMPT solution and we continued to apply the single stimulus pulses every 5 minutes.
Stimulus pulses were applied for up to 120 minutes in this case in order to capture the
increase and eventual decrease in stimulated release.
Data Analysis
For statistical comparisons, GraphPad Prism (version 4.03) software was used. Data are
expressed as a mean +/− SEM. A one-way analysis of variance with repeated measures
statistical test was used to assess within-genotype influences of stimulation frequency on
DA release (Fig. 1). Other comparisons were assessed by unpaired Student’s t-test with p <
0.05 being considered significant.
Results
Striatal DA Release
It has previously been shown using striatal brain slice preparations that upon single pulse
electrical stimulation, 12-week old R6/2 mice release significantly less DA than their age-
matched WT controls (Johnson et al., 2006). To investigate the impact of the HD mutation
on DA reserve pool mobilization, slices from 12-week old R6/2 and WT mice were
subjected to 120-pulse stimulations at 20, 30, 40, 50, and 60 Hz, and FSCV at carbon fiber
microelectrodes was used to measure DA release (Fig. 1A). Cyclic voltammograms obtained
at the highest point of stimulated release ([DA]stim) confirm that the analyte detected is
dopamine. Although the DA release in WT slices appears to increase as frequency is
increased, there was no statistically significant difference between stimulation frequencies
(Fig. 1B; ANOVA). However, at 50 and 60 Hz stimulation frequencies, [DA]stim was
significantly less in R6/2 slices than in WT slices (p < 0.05 at both frequencies). The
average values for [DA]stim at 50 Hz were 1.20 ± 0.33 µM (R6/2; n = 5 mice) and 2.71 ±
0.47 µM (WT; n = 6 mice). At 60 Hz, the values were 1.31± 0.32 µM (R6/2; n = 5 mice) and
3.34 ± 0.76 µM (WT; n = 6 mice).
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Intracellular DA Levels
The aforementioned stimulated release results shown in Fig. 1 prompted us to determine the
relative amounts of DA found in pharmacologically distinct pools. Amphetamine-induced
DA efflux measurements in brain slices of 6-week and 12-week R6/2 and WT mice were
compared. Each slice was continuously treated with 10 µM TBZ, which blocks the loading
of DA into vesicles by inhibiting VMAT (Kung et al. 1994). RRP dopamine was then
depleted by applying single-pulse stimulations every five minutes until the stimulated
release peak disappeared. At this point, the only dopamine remaining in the terminals was
reserve pool and free cytosolic DA. Slices were then exposed to 20 µM AMPH, a
competitive dopamine transporter (DAT) inhibitor that causes DA efflux from vesicles
inside presynaptic terminals. AMPH enters presynaptic terminals either by lipophilic
diffusion through membranes or by passage through DAT protein molecules. AMPH that
enters through DAT causes allosteric translocation of the transporters and thereby induces
reverse transport of DA from the cytoplasm (Liang & Rutledge 1982, Fischer & Cho 1979).
AMPH also displaces vesicular DA into the cytoplasm where it can then be released by
reverse transport (Chiueh & Moore 1975, Jones et al. 1998). Therefore, we used AMPH as a
pharmacological tool for emptying DA from presynaptic terminals into the extracellular
space. The efflux of DA was measured over the course of 25 minutes. The amplitude of the
peak ([DA]AMPH) was used to determine the amount of DA released (Fig. 2A). In six-week
old R6/2 and WT mice there was not a significant difference in the amount of AMPH
induced efflux of DA (R6/2, 11.49 ± 2.36 µM, n= 6 mice; WT, 12.41 ± 2.26 µM, n = 7
mice). However, by 12 weeks of age, the R6/2 mice showed a significant decrease in
AMPH-induced DA efflux after TBZ treatment (Fig. 2B; p = 0.023; R6/2, 5.41 ± 1.10 µM,
n= 7 mice; WT, 10.44 ± 1.65 µM, n= 8 mice).
To measure reserve pool DA more selectively, a separate set of experiments were conducted
in which slices were treated with αMPT rather than TBZ. αMPT inhibits tyrosine
hydroxylase, the rate limiting enzyme in DA synthesis. A stimulus pulse was applied every
5 minutes until the DA peak disappeared, and then AMPH was added to the aCSF perfusion
solution, in addition to the 50 µM αMPT, at a final concentration of 20 µM. The peak
amplitude of the AMPH-induced efflux, [DA]AMPH, was measured to quantify the amount
of DA stored in reserve pool vesicles (Fig. 3). At 6 weeks of age, there was not a significant
difference between R6/2 and WT mice (R6/2, 8.17 ± 1.96 µM, n= 5 mice; WT, 5.39 ± 0.88
µM, n= 3 mice). Conversely, [DA]AMPH was diminished in slices from 12-week old R6/2
mice compared to age-matched WT controls (p < 0.05; R6/2, 4.02 ± 0.74 µM, n= 5 mice;
WT, 7.75 ± 1.48 µM, n= 4 mice).
Mobilization of Reserve Pool DA
To determine if reserve pool DA is mobilized differently in older R6/2 mice compared to
age-matched WT control mice, αMPT and then COC, which has been shown to mobilize
DA reserve pools (Venton et al., 2006), were added sequentially to the perfusion solution
while measuring stimulated DA release. First, DA release, evoked by the application of
single electrical stimulus pulses, was measured using FSCV in striatal brain slices from 12-
week old R6/2 and WT mice. The pulses were applied prior to and throughout the
pharmacological treatment of each slice. Next, slices were treated with 50 µM αMPT.
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Finally, once the stimulated DA release peak disappeared, slices were treated with 20 µM
COC in addition to the αMPT. The WT slices released DA for a longer period of time (90
min) after the addition of COC in comparison to R6/2 slices (30 min; Fig. 4A). The
maximum COC-induced DA release was not significantly different between the R6/2 and
WT mice (Fig. 4B). Area under the curve calculations suggest that the R6/2 slices released
DA from fewer vesicles (41.6% of WT).
Discussion
In this study, differences in DA reserve pool storage and mobilization in striatal brain slices
from R6/2 and WT mice were examined. In R6/2 slices, electrically-induced release of
dopamine was non-responsive to increasing stimulation frequencies. However, release from
WT slices was significantly greater than that in R6/2 slices at the higher stimulation
frequencies. Moreover, AMPH-induced DA efflux was diminished in slices from R6/2 mice
at 12 weeks of age, but not at 6 weeks of age, indicative of an age-dependent deficit of
reserve pool DA in R6/2 mice. Our data also suggest that fewer DA reserve pool vesicles
were mobilized in slices from 12-week old R6/2 mice compared to slices from age-matched
WT control mice; thus, fewer reserve pool vesicles are present in the R6/2 striatum.
Previous studies using R6/2 mice have shown that DA release, evoked using a single pulse
stimulation, is impaired in brain slices from 12-week old R6/2 mice (Johnson et al., 2006).
This single pulse application causes DA to be released from the RRP which makes up only 1
to 2% of vesicles in presynaptic terminals (Rizzoli and Betz, 2005). Similarly, electrically
evoked release of DA using the 120-pulse stimulation regimen was diminished in R6/2
slices at the higher stimulation frequencies (50 and 60Hz) but not at the lower frequencies
(20, 30, and 40 HZ). Even though peak dopamine levels were observed after the application
of about 18 pulses at 60 Hz and 15 pulses at 50 Hz, a full 120 pulse regimen was applied in
an attempt to reveal genotype-related differences. A difference in [DA] between R6/2 and
WT at the end of this pulse regimen could potentially suggest a difference in the ability to
sustain dopamine release during periods of excessive stimulation. However, there was not a
significant difference between the R6/2 and WT mice. Given that the reserve pool makes up
80 to 90% of vesicular DA stores (Neves and Lagnado, 1999; Rizzoli and Betz, 2005), it
seems likely that, if these stores were mobilized, they would overwhelm and mask the
release of RRP DA. Indeed, the average magnitude of DA release, evoked by the application
of a 120-pulse train, was on the order of 3 to 4 µM from WT slices compared to about 1.5
µM evoked by application of a single stimulus pulse (Johnson et al., 2006). Thus, it is
possible that the difference in DA release between the R6/2 and WT mice at high
stimulation frequencies is driven by the mobilization of stored pool vesicles. According to
the standard three pool model, the vesicles in the RRP are released first upon mild
stimulation in which the axon terminal is depolarized by an action potential (Wu and Borst,
1999). As the RRP becomes depleted, the recycle pool vesicles mobilize (Harata et al.,
2001; de Lange et al., 2003; Kuromi and Kidokoro, 2003; Richards et al., 2003). Upon
frequent or more intense stimulation, the reserve pool vesicles mobilize (Richards et al.,
2000; Richards et al., 2003; Heien and Wightman, 2006). It has been shown that, in
anesthetized rats, reserve pool DA can be mobilized by stimulating the medial forebrain
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bundle at 5-second intervals using a stimulating frequency of 30 Hz (Yavich and
MacDonald, 2000).
Phasic DA signaling is important for the expression of behavior (Heien and Wightman,
2006). However, it is also important to note that input from cortical glutamate afferents may
exert control over behavior by driving striatal medium spiny neuron firing (Lape and Dani,
2004) and influencing DA release (Kulagina et al., 2001; Avshalumov et al., 2003). Tonic
DA levels have been proposed to restrain the excitatory effects of glutamate input by acting
primarily on dopaminergic D1 receptors (Kiyatkin and Rebec, 1999). The lower stimulation
frequencies (20 or 30 Hz) are associated more with tonic DA levels in the striatum (Hyland
et al., 2002; Heien and Wightman, 2006); therefore, because DA release was not
significantly different between R6/2 and WT at these frequencies, it appears unlikely that
differences in tonic dopamine levels play a major role in the propagation of abnormal
behaviors in these mice. Conversely, phasic bursts of DA may be associated with upper
stimulation frequencies (50 and 60 Hz); therefore, it is possible that 12-week old R6/2 mice
lack the ability to provide the needed phasic dopaminergic input required for normal motor
control, thereby contributing to the abnormal behavioral phenotype.
The DA reserve pools were examined using various pharmacological agents. Treating the
brain slices with TBZ coupled with electrical stimulation will deplete the releasable vesicles.
Upon the addition of AMPH intracellular and vesicular DA will exit the terminals by reverse
transport through the DAT into the extracellular space (Sulzer et al., 1995; Floor and Meng,
1996; Jones et al., 1998; Schwartz et al., 2005; Watanabe et al., 2005). The diminished DA
efflux in 12-week old R6/2 mice indicates that DA, not released by stimulation with a single
electrical pulse, becomes progressively depleted between 6 and 12 weeks of age. This DA is
made up of reserve pool DA and free cytosolic DA. Similar results were obtained when
reserve pool DA was selectively isolated by treatment of slices with αMPT, which, when
combined with electrical stimulation, depletes releasable DA stores and free cytosolic DA.
R6/2 mice typically develop the overt motor phenotype at 9 to 11 weeks of age; thus, the
timescale of reserve pool depletion is consistent with the occurrence of motor symptoms.
More commonly known as a dopamine uptake inhibitor, COC has a similar affinity for DAT
in R6/2 mice as compared to WT mice (Johnson et al, 2006). Thus, the differences in release
measured after treating R6/2 and WT slices with COC following pre-treatment with αMPT
most likely arise from differences in the stimulated release of the mobilized DA reserve
pool, not differences in uptake. Because the peak DA levels evoked by single pulse
electrical stimulation are the same in R6/2 and WT control slices under these conditions, it is
likely that R6/2 mice can mobilize reserve pool vesicles normally, and that the vesicles
contain the same number of DA molecules. These results also imply that there are similar
densities of DA-releasing presynaptic terminals in the R6/2 and WT striata. However, the
DA release lasted roughly three times as long in slices from WT mice compared to slices
from R6/2 mice, suggesting that R6/2 mice suffer from a depletion in the number of DA
reserve pool vesicles (approximately 41.6% of WT, according to area under the curve
calculations). Although the normal intracellular functions of the endogenous Htt protein are
not fully understood, recent studies have shown that the expanded CAG repeat, along with
promoting the formation of aggregates in neurons of both HD model mice and people who
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have HD (Cooper et al., 1998; Hazeki et al., 1999; Meade et al., 2002), can also cause
impairments in vesicular transport (Edwardson et al., 2003; Morton et al., 2001; Li et al.,
2003). It is therefore possible that the R6/2 mice have fewer reserve pool vesicles because
they are unable to transport vesicles or maintain vesicles in the reserve pool as well as WT
mice.
Collectively, our data suggest that an age-dependent loss of DA reserve pool vesicles may
contribute to the progressive behavioral phenotype of R6/2 mice. These findings may help
guide the development of therapeutic interventions to treat chorea and other motor
syndromes associated with HD. Additionally, future research efforts may be aimed at
resolving the cellular mechanisms that are responsible for the depletion of the DA reserve
pool.
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aCSF artificial cerebral spinal fluid
AMPH amphetamine
COC cocaine
DA dopamine
DAT dopamine transporter
FSCV fast scan cyclic voltammetry
HD Huntington’s disease
htt huntingtin
METH methamphetamine
αMPT alpha-methyl-p-tyrosine
RRP readily releasable pool
TBZ tetrabenazine
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Figure 1.
Striatal DA release, evoked by the application of 120-pulse stimulus pulse trains, is impaired in R6/2 brain slices compared to
WT brain slices. (A) Representative plots and cyclic voltammograms obtained by FSCV at carbon-fiber microelectrodes for
R6/2 and WT mice are shown. The representative plots where taken using a 60 Hz stimulation frequency. The duration of the
stimulation is represented by the bar under each plot. The cyclic voltammograms confirm the presence of DA. (B) DA release
was evoked by 20, 30, 40, 50, and 60 Hz 120-pulse stimulus trains. [DA]stim was significantly greater in WT brain slices
compared to R6/2 brain slices when evoked using 50Hz and 60 Hz stimulus frequencies (*p < 0.05 at 50 and 60 Hz; n = 5 R6/2
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mice and 6 WT mice). Although striatal DA release appears to increase with increasing frequency in WT slices, differences in
release between application frequencies are not significant within either genotype (one-way ANOVA).
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Figure 2.
AMPH induced DA efflux after TBZ treatment is impaired in 12-week old R6/2 mice compared to WT mice. (A) Representative
data from a 6-week old WT mouse. The brain slice was exposed to 20 µM TBZ while applying single, 4 ms duration stimulus
pulses (one pulse every 5 minutes) until DA release disappeared. The slice was then exposed to 20 µM AMPH for 25 minutes,
and [DA]AMPH was measured. A CV is provided at peak release and confirms the presence of DA. Stimulated release plots were
collected every 5 minutes, but are shown every 10 minutes for clarity. (B) In 12-week old R6/2 mice, [DA]AMPH is significantly
less than in WT mice (*p < 0.05; n = 7 R6/2 mice and 8 WT mice), but at 6-weeks of age there is not a significant difference
between the two sets of mice (p > 0.05; n = 6 R6/2 and 7 WT mice).
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Figure 3.
AMPH induced DA efflux after αMPT treatment is diminished in older R6/2 mice. (A) Representative data from a 6-week old
WT mouse. Slices were treated with 50 µM αMPT until the stimulated DA release peak disappeared. The slice was then
exposed to 20 µM AMPH for 25 minutes and [DA]AMPH was measured. The last 20 minutes of AMPH treatment are shown in
this particular plot. A CV is provided at peak release and confirms the presence of DA. Stimulated release plots collected every
10 minutes are shown for clarity. (B) AMPH induced DA efflux was not significantly different between 6-week old R6/2 and
WT brain slices (p > 0.05; n = 5 R6/2 and 3 WT mice). [DA]AMPH was significantly decreased in slices from 12-week old R6/2
mice compared to those from age-matched WT control mice (*p < 0.05; n = 5 R6/2 mice and 4 WT mice).
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Figure 4.
Reserve pool vesicles are depleted in 12-week old R6/2 mice. Slices were treated with 50 µM αMPT while applying a 4 ms
duration single-pulse electrical stimulus every 5 minutes. Once the stimulated DA release peak disappeared, 20 µM COC was
added to the brain slice and the application of stimulus pulses continued. Stimulated DA release was measured by FSCV. (A)
Representative data from R6/2 and WT slices. Reserve pool mobilization by COC resulted in measurable stimulated DA release.
Stimulated release plots collected immediately after the addition of αMPT and the disappearance of the DA release peak have
been omitted in this figure for clarity. (B) Pooled data from R6/2 and WT mice. Each data point represents the average value (±
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SEM) of [DA]stim obtained from 5 R6/2 mice and 6 WT mice. The maximum peak amplitudes obtained in R6/2 and WT slices
were not significantly different.
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